SCHEMBL5230610

SCHEMBL5230610

CC(C)(C)OC(=O)N1CCCN(c2ccc(F)cc2)CC1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
MAPT P10636 2/20 0.61
LMNA P02545 1/20 0.61
ALOX15 P16050 1/20 0.54
GPR119 Q8TDV5 5/20 0.54
NAMPT P43490 1/20 0.53
PDK2 Q15119 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
CYP2C19 P33261 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
POLB P06746 1/20 0.50
CKS1B P61024 1/20 0.50
SKP1 P63208 1/20 0.50
SKP2 Q13309 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20142379 0.94 ALDH1A1 (0.67) ALDH1A1MAPTLMNAALOX15GPR119
SCHEMBL941160 0.90 ALDH1A1 (0.62) ALDH1A1MAPTLMNAALOX15GPR119
SCHEMBL5231173 0.88 GPR119 (0.70) ALDH1A1MAPTLMNAGPR119NAMPT
SCHEMBL13281422 0.88 MAPT (0.62) ALDH1A1MAPTLMNAGPR119NAMPT
SCHEMBL5573222 0.87 MAPT (0.76) ALDH1A1MAPTLMNAGPR119NAMPT
SCHEMBL5231271 0.87 MAPT (0.67) ALDH1A1MAPTLMNAGPR119NAMPT
SCHEMBL5236861 0.86 MAPT (0.61) ALDH1A1MAPTLMNAGPR119NAMPT
SCHEMBL3194630 0.86 MAPT (0.61) ALDH1A1MAPTLMNAGPR119NAMPT
SCHEMBL411201 0.86 MAPT (0.61) ALDH1A1MAPTLMNAGPR119NAMPT
SCHEMBL1257264 0.86 MEN1 (0.70) ALDH1A1MAPTLMNAALOX15GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025038930-A1 AZEPANE AND PYRROLIDINE COMPOUNDS AND USES THEREOF XENON PHARMACEUTICALS, INC. (CA) 2025-02-20 WO disclosed
US-20240199555-A1 APPLICATIONS OF BIASED LIGANDS OF THE SEROTONIN 5-HT7 RECEPTOR FOR THE TREATMENT OF PAIN, MULTIPLE SCLEROSIS AND THE CONTROL OF THERMOREGULATION Université d'Orléans (FR) 2024-06-20 US disclosed
EP-4308119-A1 <SUP2/>? <SUB2/>?7?APPLICATIONS OF BIASED LIGANDS OF THE SEROTONIN 5-HTRECEPTOR FOR THE TREATMENT OF PAIN, MULTIPLE SCLEROSIS AND THE CONTROL OF THERMOREGULATION Centre National de la Recherche Scientifique (FR) 2024-01-24 EP disclosed
WO-2022195102-A1 APPLICATIONS OF BIASED LIGANDS OF THE SEROTONIN 5-HT7 RECEPTOR FOR THE TREATMENT OF PAIN, MULTIPLE SCLEROSIS AND THE CONTROL OF THERMOREGULATION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2022-09-22 WO disclosed
WO-2018089493-A1 PYRROLE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20070219234-A1 Thienopyridine Derivatives SANKYO COMPANY, LIMITED (JP) 2007-09-20 US disclosed
EP-1764367-A1 THIENOPYRIDINE DERIVATIVES Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219234-A1 Thienopyridine Derivatives RASGRP1, NRAS, HRH3 ALDH1A1 1073/4885MAPT 4452/4885LMNA 4549/4885
US-20240199555-A1 APPLICATIONS OF BIASED LIGANDS OF THE SEROTONIN 5-HT7 RECEPTOR FOR THE TREATMENT OF PAIN, MULTIPLE SCLEROSIS AND THE CONTROL OF THERMOREGULATION HTR7, HTR1A, CNR1 ALDH1A1 1323/4885MAPT 2791/4885LMNA 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.